alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit
      32.2**





CERTIFICATION
      PURSUANT TO


18
      U.S.C. SECTION
      1350,


AS
      ADOPTED PURSUANT
      TO


SECTION
      906 OF THE
      SARBANES-OXLEY ACT OF 2002





In
      connection with
      the report of Med-Emerg International Inc. (the "Company") on Form 10-K for
      the
      period ended December 31, 2004 as filed with the Securities and Exchange
      Commission on the date hereof (the "Report"), I, William Danis Chief Financial
      Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted
      pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my
      knowledge:








1) The
      Report fully
      complies with the requirements of section 13(a) or 15(d) of the Securities
      Exchange Act of 1934; and





2) The
      information
      contained in the Report fairly presents, in all material respects, the financial
      condition and result of operations of the Company.





Dated: November
                30, 2005By:
                /s/
                William DanisName:
                William
                DanisTitle:
                Chief
                Financial Officer
EXHIBIT 32


CERTIFICATION PURSUANT TO SECTION 906

Pursuant to 18 U.S.C. Section 1350 as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, I, the
undersigned officer of the Greenrock Ventures, Inc.
(the "Company"), hereby certify to my knowledge that:

The Report on Form 10-Q for the period ended September 30,
2009 of the Company fully complies, in all material respects,
with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, and the information contained in the
Report fairly represents, in all material respects, the
financial condition and results of operations of the Company.

A signed original of this written statement required by Section
906 has been provided to the Company and will be retained by
the Company and furnished to the Securities and Exchange
Commission or its staff upon request.


                                 /s/ William Tay
                                 ----------------------------
                                 President and Director and
                                 Chief Executivie Officer,
                                 Chief Financial Officer and
                                 Principal Accounting Officer
Date: October 27, 2009
Exhibit 99.7

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Minera Andes Inc. (the Corporation) on Form 40-F for the twelve month period ended December 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the
Report), I, Allen V. Ambrose, President and Chief Executive Officer of the Corporation, certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my
knowledge:



| | 1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------



|      |  |                  |  |                   |  |                                      
|----- |  | ---------------- |  | ----------------- |  | -------------------------------------
|      |  |                  |  | MINERA ANDES INC.
|      |  |                  | 
|Date: |  | October 16, 2008 |  | By:               |  | /s/ Allen V. Ambrose                 
|      |  |                  |  |                   |  | Allen V. Ambrose                     
|      |  |                  |  |                   |  | President and Chief Executive Officer

A signed original of this written statement required by Rule 13a- 14(b) of the Securities
Exchange Act of 1934 and 18 U.S.C. Section 1350 has been provided to Minera Andes, Inc. and will be retained by Minera Andes, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Form 40-F to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to
be incorporated by reference into any filing of the Registrant under the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made before or after the date of the Form 40-F), irrespective of any general incorporation language
contained in such filing.
NOTE: This order is nonprecedential.

United States Court of Appeals 

for the Federal Circuit ______________________

U.S. WELL SERVICES, LLC, PROFRAC 

HOLDING CORP., 

Appellants

v.

HALLIBURTON ENERGY SERVICES, INC., 

Appellee

______________________

2023-1706

______________________

Appeal from the United States Patent and Trademark 

Office, Patent Trial and Appeal Board in No. IPR2021-

01315.

______________________

O R D E R

The parties having so agreed, it is ordered that:

(1) The proceeding is DISMISSED under Fed. R. App. 

P. 42 (b).

(2) Each side shall bear their own costs.

FOR THE COURT

July 20, 2023

Date /s/ Jarrett B. Perlow

Jarrett B. Perlow 

Clerk of Court

ISSUED AS A MANDATE: July 20, 2023

Case: 23-1706 Document: 11 Page: 1 Filed: 07/20/2023
<PAGE>


                                                                    Exhibit 23.2
                                [KPMG LETTERHEAD]

                              ACCOUNTANTS' CONSENT

The Board of Directors
 Med-Emerg International Inc.

We consent to the use of our audit report dated March 26, 1997 (except for Notes
2, 11, 12, and19 for which the date is January 27, 1998) on the consolidated
balance sheet of Med-Emerg International Inc. as at December 31, 1996, and the
consolidated statements of income, retained earnings (deficit) and changes in
financial position for each of the years in the two year period ended December
31, 1996 included herein.




/s/ KPMG

KPMG, Chartered Accountants
Mississauga, Ontario, Canada
May 17, 1999
Exhibit 99.7

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In
connection with the Annual Report of Minera Andes Inc. (the Corporation) on Form 40-F for the twelve month period ended December 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the
Report), I, Allen V. Ambrose, President and Chief Executive Officer of the Corporation, certify, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my
knowledge:



| | 1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | ---------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------



|                     |  |  |  |                   |  |                                      
|-------------------- |  |  |  | ----------------- |  | -------------------------------------
|                     |  |  |  | MINERA ANDES INC.
|                     |  |  | 
|Date: March 26, 2008 |  |  |  | By:               |  | /s/ Allen V. Ambrose                 
|                     |  |  |  |                   |  | Allen V. Ambrose                     
|                     |  |  |  |                   |  | President and Chief Executive Officer

A signed original of this written statement required by Rule 13a- 14(b) of the Securities Exchange Act of 1934
and 18 U.S.C. Section 1350 has been provided to Minera Andes, Inc. and will be retained by Minera Andes, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies the Form 40-F to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated
by reference into any filing of the Registrant under the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made before or after the date of the Form 40-F), irrespective of any general incorporation language contained in such
filing.
EXHIBIT 3.4  Amendment
to Bylaws adopted in December 2001:  Article III, Section 2 of the Bylaws is
hereby amended in its entirety as follows:  Section 2. Number and Qualification of Directors. The number of
directors of the corporation shall be six (6).   Amendment to Bylaws adopted in August
2002:  Article VII, Section 1 of the Bylaws is
hereby amended to add the following sentence at the end thereof:  Notwithstanding the foregoing, however, for
purposes of determining the stockholders entitled to receive payment of any
dividend issued pursuant to a stockholders rights plan, the board of directors
may fix, in advance, a record date, which record date shall not precede the
date upon which the resolution fixing the record date is adopted by the board of
directors, and which record date shall not be more than sixty (60) days prior
to such payment.
I 

115TH CONGRESS 

2D SESSION H. R. 5999 

To direct the Securities and Exchange Commission to revise section 230.163 

of title 17, United States Code, to apply the exemption offered in such 

section to communications made by underwriters and dealers acting by 

or on behalf of a well-known seasoned issuer. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 5, 2018 

Mr. BUDD introduced the following bill; which was referred to the Committee 

on Financial Services 

A BILL 

To direct the Securities and Exchange Commission to revise 

section 230.163 of title 17, United States Code, to apply 

the exemption offered in such section to communications 

made by underwriters and dealers acting by or on behalf 

of a well-known seasoned issuer. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Streamlining Commu5 nications for Investors Act’’. 


lotter on DSKBCFDHB2PROD with BILLS
2 

•HR 5999 IH

1 SEC. 2. EXEMPTION OF COMMUNICATIONS MADE BY UN2 DERWRITERS AND DEALERS ACTING BY OR 

3 ON BEHALF OF WELL-KNOWN SEASONED 

4 ISSUER. 

5 (a) IN GENERAL.—Not later than 120 days after the 

6 date of the enactment of this section, the Securities and 

7 Exchange Commission shall revise section 230.163(c) of 

8 title 17, United States Code, to apply the exemption of9 fered in section 230.163 of title 17, United States Code, 

10 to written and oral communications made by an under11 writer or dealer acting by or on behalf of a well-known 

12 seasoned issuer if, before such a communication is made— 

13 (1) the underwriter or dealer making such com14 munication receives written authorization from the 

15 well-known seasoned issuer to act as its agent or 

16 representative; and 

17 (2) the well-known seasoned issuer authorized 

18 or approved such communication. 

19 (b) INCLUSION IN PROSPECTUS.—A well-known sea20 soned issuer shall identify in the prospectus filed for an 

21 offering each underwriter or dealer that has made oral or 

22 written communications related the offering in reliance on 

23 the exemption under section 230.163 of title 17, United 

24 States Code. 

Æ 


lotter on DSKBCFDHB2PROD with BILLS
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[S. 1503 Engrossed in Senate (ES)]

  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
106th CONGRESS
  1st Session
                                S. 1503

_______________________________________________________________________

                                 AN ACT

 
To amend the Ethics in Government Act of 1978 (5 U.S.C. App.) to extend 
the authorization of appropriations for the Office of Government Ethics 
                       through fiscal year 2003.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Office of Government Ethics 
Authorization Act of 1999''.

SEC. 2. EXTENSION OF AUTHORIZATION OF APPROPRIATIONS.

    Section 405 of the Ethics in Government Act of 1978 (5 U.S.C. App.) 
is amended by striking ``1997 thorough 1999'' and inserting ``2000 
through 2003''.

SEC. 3. EFFECTIVE DATE.

    This Act shall take effect on October 1, 1999.

            Passed the Senate November 19, 1999.

            Attest:

                                                             Secretary.
106th CONGRESS

  1st Session

                                S. 1503

_______________________________________________________________________

                                 AN ACT

To amend the Ethics in Government Act of 1978 (5 U.S.C. App.) to extend 
the authorization of appropriations for the Office of Government Ethics 
                       through fiscal year 2003.
```
Exhibit 32.1





CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of First Savings Financial Group, Inc. and Subsidiaries (the "Company") on Form 10-Q for the period ended March 31, 2011, as filed with the Securities and Exchange Commission (the "Report"), I, Larry W. Myers, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:





(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.




DATE:  May 13, 2011
BY:
/s/ Larry W. MyersLarry W. MyersPresident and Chief Executive Officer
EXHIBIT 32.2
  CERTIFICATION PURSUANT TO
  18 U.S.C. §1350,
  AS ADOPTED PURSUANT TO
  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  In connection with the Annual Report of Vascular Solutions, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2010, as filed with the Securities and Exchange Commission (the “Report”), I, James Hennen, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
 
 1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
  2.
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
  
 /s/ James HennenJames Hennen

Chief Financial Officer

February 1, 2011
```

[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[S. 157 Introduced in Senate (IS)]

106th CONGRESS
  1st Session
                                 S. 157

  To amend the Internal Revenue Code of 1986 to tax 9 millimeter, .25 
                   caliber, and .32 caliber bullets.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 19, 1999

 Mr. Moynihan introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
  To amend the Internal Revenue Code of 1986 to tax 9 millimeter, .25 
                   caliber, and .32 caliber bullets.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Real Cost of Handgun Ammunition Act 
of 1999''.

SEC. 2. INCREASE IN TAX ON CERTAIN BULLETS.

    (a) In General.--Section 4181 of the Internal Revenue Code of 1986 
(relating to the imposition of tax on firearms, etc.) is amended by 
adding at the end the following new flush sentence:
``In the case of 9 millimeter, .25 caliber, or .32 caliber ammunition, 
the rate of tax under this section shall be 1,000 percent.''
    (b) Exemption for Law Enforcement Purposes.--Section 4182 of the 
Internal Revenue Code of 1986 (relating to exemptions) is amended by 
adding at the end the following new subsection:
    ``(d) Law Enforcement.--The last sentence of section 4181 shall not 
apply to any sale (not otherwise exempted) to, or for the use of, the 
United States (or any department, agency, or instrumentality thereof) 
or a State or political subdivision thereof (or any department, agency, 
or instrumentality thereof).''
    (c) Effective Date.--The amendments made by this section shall 
apply to sales after December 31, 1999.
                                 <all>
```
[Federal Register Volume 73, Number 39 (Wednesday, February 27, 2008)]
[Notices]
[Page 10456]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-854]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, Clinical Agents and Specimen 
Repository.
    Date: March 20, 2008.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Rockledge 6700, 6700B 
Rockledge Drive, Bethesda, MD 20817. (Telephone Conference Call)
    Contact Person: Marilyn Khanna, PhD, Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institutes of Health/NIAID, 6700B Rockledge Drive, Rm. 
3254, MSC 7616, Bethesda, MD 20892-7616, 301-402-4228, 
<a href="/cdn-cgi/l/email-protection#98f3f0f9f6f6f9f5f9d8f6f1f9f1fcb6f6f1f0b6fff7ee"><span class="__cf_email__" data-cfemail="650e0d040b0b040804250b0c040c014b0b0c0d4b020a13">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


    Dated: February 20, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 08-854 Filed 2-26-08; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# C_2010275EN.01000601.xml

| 12.10.2010 | EN | Official Journal of the European Union | C 275/6 |
| --- | --- | --- | --- |

12.10.2010

EN

Official Journal of the European Union

C 275/6

---

Euro exchange rates (1)

1

11 October 2010

2010/C 275/07

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,3936 |
| JPY | Japanese yen | 114,24 |
| DKK | Danish krone | 7,4577 |
| GBP | Pound sterling | 0,87460 |
| SEK | Swedish krona | 9,2715 |
| CHF | Swiss franc | 1,3412 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 8,1235 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 24,542 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 274,03 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,7090 |
| PLN | Polish zloty | 3,9605 |
| RON | Romanian leu | 4,2668 |
| TRY | Turkish lira | 1,9680 |
| AUD | Australian dollar | 1,4153 |
| CAD | Canadian dollar | 1,4100 |
| HKD | Hong Kong dollar | 10,8131 |
| NZD | New Zealand dollar | 1,8523 |
| SGD | Singapore dollar | 1,8197 |
| KRW | South Korean won | 1 560,69 |
| ZAR | South African rand | 9,6019 |
| CNY | Chinese yuan renminbi | 9,2922 |
| HRK | Croatian kuna | 7,3203 |
| IDR | Indonesian rupiah | 12 439,09 |
| MYR | Malaysian ringgit | 4,3223 |
| PHP | Philippine peso | 60,605 |
| RUB | Russian rouble | 41,5750 |
| THB | Thai baht | 41,857 |
| BRL | Brazilian real | 2,3198 |
| MXN | Mexican peso | 17,2861 |
| INR | Indian rupee | 61,9320 |

Currency

Exchange rate

USD

US dollar

1,3936

JPY

Japanese yen

114,24

DKK

Danish krone

7,4577

GBP

Pound sterling

0,87460

SEK

Swedish krona

9,2715

CHF

Swiss franc

1,3412

ISK

Iceland króna

NOK

Norwegian krone

8,1235

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

24,542

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

274,03

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,7090

PLN

Polish zloty

3,9605

RON

Romanian leu

4,2668

TRY

Turkish lira

1,9680

AUD

Australian dollar

1,4153

CAD

Canadian dollar

1,4100

HKD

Hong Kong dollar

10,8131

NZD

New Zealand dollar

1,8523

SGD

Singapore dollar

1,8197

KRW

South Korean won

1 560,69

ZAR

South African rand

9,6019

CNY

Chinese yuan renminbi

9,2922

HRK

Croatian kuna

7,3203

IDR

Indonesian rupiah

12 439,09

MYR

Malaysian ringgit

4,3223

PHP

Philippine peso

60,605

RUB

Russian rouble

41,5750

THB

Thai baht

41,857

BRL

Brazilian real

2,3198

MXN

Mexican peso

17,2861

INR

Indian rupee

61,9320

---

(1)  Source: reference exchange rate published by the ECB.

1

Source

---
[Federal Register Volume 73, Number 37 (Monday, February 25, 2008)]
[Notices]
[Page 10006]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-844]


=======================================================================
-----------------------------------------------------------------------

COMMODITY FUTURES TRADING COMMISSION


Sunshine Act Meetings

AGENCY HOLDING THE MEETING: Commodity Futures Trading Commission.

TIME AND DATE: 11 a.m., Friday March 7, 2008.

PLACE: 1155 21st St., NW., Washington, DC, 9th Floor Commission 
Conference Room.

STATUS: Closed.

MATTERS TO BE CONSIDERED: Surveillance Matters.

FOR FURTHER INFORMATION CONTACT: Sauntia S. Warfield, 202-418-5084.

David A. Stawick,
Secretary of the Commission.
[FR Doc. 08-844 Filed 2-21-08; 11:53 am]
BILLING CODE 6351-01-M
COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

IN RE: PURPORTED MECHANICAL 

AND MATERIALMAN’S LIEN CLAIM 

OF LIEN AGAINST PELLICANO 

BUSINESS PARK, L.L.C.,

 

 Appellant. 

§

§

§

§

§

§

§

No. 08-16-00291-CV

Appeal from the

County Court at Law No. 7

of El Paso County, Texas 

(TC# 2012-DCV06341)

O R D E R

Pending before the Court is Appellant’s motion to stay the mandate. Rule 18.2 provides 

that a party may move to stay issuance of the mandate pending the United States Supreme Court’s 

disposition of a petition for writ of certiorari. TEX.R.APP.P. 18.2. The mandate issued in this case 

on December 20, 2018. The motion is DENIED.

IT IS SO ORDERED this 23rd day of January, 2019.

PER CURIAM

Before McClure, C.J., Rodriguez and Palafox, JJ.